Upsher-Smith is a trusted U.S. Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company striving to improve the health and lives of patients.
pharmaceutical company striving to improve the health and lives of patients by manufacturing and marketing generic and brand pharmaceutical products across multiple therapeutic areas. We formulate and manufacture generics and brands for a wide array of customers, backed by our attentive level of service, our strong industry relationships, and our dedication to uninterrupted supply.
10/08/2025
October marks American Pharmacists Month, and Upsher-Smith is proud to celebrate the pharmacists who make healthcare work. From improving patient outcomes to advancing medication safety, your expertise and compassion are the backbone of our communities. đź’Šđź’™
10/07/2025
Upsher-Smith will be attending the 2025 Child Neurology Society (CNS) Annual Meeting in Charlotte, NC from October 8-11!
Stop by Booth #701 to explore our product offerings, including the
first and only premixed oral solution for infantile spasms, and learn
about our comprehensive support program designed for patients,
caregivers, and healthcare providers.
We look forward to connecting with the neurology community and
sharing how we’re working to make a difference for those affected by rare diseases.
09/18/2025
Upsher-Smith has launched Difluprednate Ophthalmic Emulsion 0.05%. Click below to learn more about the product and its availability.
Read this post on the Upsher-Smith website.
09/07/2025
On (September 7), we honor the strength of individuals and families impacted by Duchenne muscular dystrophy (DMD), as well as the dedicated healthcare professionals and staff who provide care, guidance, and hope every day.
At Upsher-Smith, we’re committed to going beyond the prescription—partnering with a best-in-class specialty pharmacy to provide personalized support with real choices. Because with DMD, every moment matters.
As a proud sponsor of Jett Foundation's annual community event to acknowledge World Duchenne Awareness Day, we’re honored to stand alongside advocacy leaders and continue working toward a future of greater access, support, and hope.
07/22/2025
Last Thursday, Upsher-Smith and our parent company, Bora Pharmaceuticals, had the honor of hosting Iowa Governor Kim Reynolds and her team at our Maple Grove, MN headquarters for a meaningful discussion on strengthening U.S. pharmaceutical manufacturing through regional collaboration.
Governor Reynolds toured our state-of-the-art facility and joined a roundtable focused on advancing pharmaceutical innovation, expanding domestic manufacturing, and building a more resilient U.S. supply chain.
We’re proud to be part of a growing regional effort to invest in people, infrastructure, and partnerships that support high-quality, accessible healthcare.
Thank you, Governor Reynolds, for your leadership and commitment to revitalizing American manufacturing.
04/28/2025
This past weekend, our Upsher-Smith Key Account Manager (KAM) Kerri Romagna proudly represented us at the 18th Annual Pediatric Neurology Symposium in Memphis. The symposium, held from April 25-26, 2025, was organized by the Neuroscience Institute at Le Bonheur Children’s Hospital. It aimed to enhance the competence and performance of healthcare providers by improving their understanding of nervous system disorders, emerging therapies, and novel imaging modalities. We look forward to learning about the valuable insights and connections Kerri brings back from this important event!
04/26/2025
Today is National Prescription Drug Take Back Day!
Join us in making a difference by safely disposing of your expired, unwanted, or unused medications. This initiative, led by the DEA, provides a safe, convenient, and anonymous way to prevent prescription drug misuse and protect our communities.
🕙 Date & Time: Saturday, April 26, 2025, from 10 a.m. to 2 p.m. 📍 Find a Collection Site: DEATakeBack.com
By participating, you help reduce the risk of medications falling into the wrong hands and contribute to a healthier, safer environment. Let's work together to combat prescription drug misuse and raise awareness about the importance of proper medication disposal.
đź’Š Accepted Items: Tablets, capsules, patches, and other solid forms of prescription drugs. Va**ng devices and cartridges are also accepted if the lithium batteries are removed. (Note: Syringes, sharps, and illicit substances will not be collected.)
For those unable to participate today, remember that nearly 17,000 pharmacies, hospitals, clinics, and law enforcement locations offer year-round drug disposal options.
Let's make our communities safer, one prescription at a time.
04/16/2025
We’re live at the Cook Children's Health Care System’s 2025 Pediatric Neurosciences Conference: Meeting of the Mind on April 16-17 in Fort Worth! 🧠✨
Upsher-Smith is honored to be part of the conversation—supporting the neuroscience community with resources that we hope will make a difference in the lives of patients and their families.
Stop by to learn more about our rare disease portfolio, including our ready-to-use oral solution for infantile spasms.
04/07/2025
Our Upsher-Smith booth is all polished up and ready to welcome AAN visitors. Be sure to stop by—we'd be delighted to answer your questions about our rare disease portfolio, including the first and only ready-to-use oral solution for infantile spasms.
04/06/2025
Upsher-Smith is proud to sponsor Comedy for a Cure and support the TSC Alliance in their efforts to help patients and families affected by tuberous sclerosis complex. Don't miss the show tonight!
We are so excited for the 24th Annual Comedy for a Cure taking place this Sunday, April 6 at Vibiana in Los Angeles, CA!
Thank you to our generous sponsors for making this event possible:
Headline sponsor Jazz Pharmaceuticals and Bravo sponsors, The Ramesh and Kalpana Bhatia Family Foundation, BRV Sharma Family, CVS Health, The Seraphina Holmes Charitable Fund, The Szilagyi/LaGraff Family and Upsher-Smith Laboratories, LLC.
There is still time to purchase tickets and sponsorships at comedyforacure.org.
02/28/2025
At Upsher-Smith, we are deeply committed to driving awareness and treatment of rare diseases. One of our key initiatives is a specialized product and patient program that provides crucial support to those affected by infantile spasms (IS) - a severe seizure disorder that affects infants and is often associated with the rare genetic condition tuberous sclerosis complex (TSC). We are honored to collaborate with and support the incredible efforts of organizations such as the Infantile Spasms Action Network, TSC Alliance, LGS Foundation, Child Neurology Foundation, and many others.
Together, we are making strides in improving the lives of patients and their families, ensuring they receive the care and attention they deserve. Our dedication to this cause is unwavering, and we will continue to champion the needs of those living with rare diseases.
02/12/2025
Continuing Our Commitment to Quality and Partnership
At Upsher-Smith, our dedication to providing high-quality products and exceptional customer service remains stronger than ever.
We are focused on expanding our generics and brand portfolio while seeking new partners to better serve patients and healthcare professionals. You can continue to rely on us for an uninterrupted supply.
Our goal, as always, is to make a meaningful impact in the healthcare industry. We are committed to enhancing the quality of life for patients and their families through life-changing therapies.
Be the first to know and let us send you an email when Upsher-Smith posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company that strives to improve the health and lives of patients through an unwavering commitment to high-quality products and sustainable growth. Since 1919, we’ve formulated and manufactured specialty generics and other products, either independently or with partners, for a wide array of customers, backed by our attentive level of service, our strong industry relationships, and our dedication to uninterrupted supply.
As we celebrate our 100th year in business, we enter a new ambitious era that has been accelerated by our 2017 acquisition by Sawai Pharmaceutical Co., Ltd. With our new owner, we look to leverage each other for growth worldwide and embark on an exciting new chapter. Together, we seek to deliver the best value for our stakeholders, and most importantly, do more good for the patients we serve.